HomeComparePVNC vs PFE

PVNC vs PFE: Dividend Comparison 2026

PVNC yields 57.14% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PVNC wins by $516.2K in total portfolio value
10 years
PVNC
PVNC
● Live price
57.14%
Share price
$3.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$565.8K
Annual income
$127,359.58
Full PVNC calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PVNC vs PFE

📍 PVNC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPVNCPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PVNC + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PVNC pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PVNC
Annual income on $10K today (after 15% tax)
$4,857.14/yr
After 10yr DRIP, annual income (after tax)
$108,255.64/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PVNC beats the other by $85,935.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PVNC + PFE for your $10,000?

PVNC: 50%PFE: 50%
100% PFE50/50100% PVNC
Portfolio after 10yr
$307.7K
Annual income
$76,809.15/yr
Blended yield
24.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PVNC
No analyst data
Altman Z
-97.6
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PVNC buys
0
PFE buys
0
No recent congressional trades found for PVNC or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPVNCPFE
Forward yield57.14%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$565.8K$49.6K
Annual income after 10y$127,359.58$26,258.71
Total dividends collected$464.7K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PVNC vs PFE ($10,000, DRIP)

YearPVNC PortfolioPVNC Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$16,414$5,714.29$9,153$693.39+$7.3KPVNC
2$26,329$8,765.97$8,593$849.25+$17.7KPVNC
3$41,313$13,141.14$8,336$1,066.78+$33.0KPVNC
4$63,476$19,270.90$8,437$1,384.80+$55.0KPVNC
5$95,591$27,671.86$9,013$1,875.40+$86.6KPVNC
6$141,229$38,945.95$10,306$2,680.72+$130.9KPVNC
7$204,890$53,775.28$12,820$4,101.38+$192.1KPVNC
8$292,144$72,911.59$17,673$6,826.70+$274.5KPVNC
9$409,754$97,160.29$27,543$12,591.86+$382.2KPVNC
10$565,797$127,359.58$49,560$26,258.71+$516.2KPVNC

PVNC vs PFE: Complete Analysis 2026

PVNCStock

Prevention Insurance.Com does not have significant operations. The company intends to pursue a business combination through acquisition or merger with an existing company. Previously, it was involved in health and life insurance agency business. The company was formerly known as Vita Plus Industries, Inc. and changed its name to Prevention Insurance.Com in March 1999. Prevention Insurance.Com was incorporated in 1975 and is based in Melbourne, Australia. Prevention Insurance.Com is a subsidiary of Copper Hill Assets Inc.

Full PVNC Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PVNC vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PVNC vs SCHDPVNC vs JEPIPVNC vs OPVNC vs KOPVNC vs MAINPVNC vs JNJPVNC vs MRKPVNC vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.